Literature DB >> 7783417

Down-regulation of PTH-PTHrP receptor of heart in CRF: role of [Ca2+]i.

M Smogorzewski1, J Tian, S G Massry.   

Abstract

The mRNA of PTH-PTHrP receptor in the kidney and liver of CRF rats is down-regulated. It is not known whether this is a generalized phenomenon and the signals that mediate such down-regulation are not evident. Excess PTH in CRF induces a rise in basal levels of cytosolic calcium ([Ca2+]i), and the high [Ca2+]i is implicated in the genesis of cell dysfunction in CRF. Therefore, it is reasonable to propose that the PTH-induced rise in [Ca2+]i provides a negative feedback control system for the down-regulation of the mRNA of the PTH-PTHrP in order to protect the cells from the harmful effects of progressive rise in blood levels of PTH in CRF. The heart contains the mRNA for this receptor and it is a target organ for PTH action. We examined whether the message of the PTH-PTHrP receptor is down-regulated in the heart of CRF animals and evaluated the role of [Ca2+]i in this process. The expression of the mRNA of the PTH-PTHrP was significantly reduced in the heart of CRF rats as compared to normal animals. Also, the CRF rats had elevated blood levels of PTH and high [Ca2+]i of cardiac myocytes. The parathyroidectomy of CRF rats prevented the rise in blood PTH levels and normalized [Ca2+]i of cardiac myocytes and returned the mRNA of their PTH-PTHrP receptor towards normal levels. The treatment of CRF rats with verapamil normalized [Ca2+]i of cardiac myocytes and returned the mRNA of their PTH-PTHrP receptor towards normal levels, despite marked elevation of blood levels of PTH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783417     DOI: 10.1038/ki.1995.168

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.

Authors:  Cecilia Marini; Massimo Giusti; Riccardo Armonino; Giorgio Ghigliotti; GianPaolo Bezante; Lara Vera; Silvia Morbelli; Elena Pomposelli; Michela Massollo; Patrizia Gandolfo; Francesco Minuto; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-04       Impact factor: 9.236

2.  Expression of bone type 1 PTH receptor in rats with chronic renal failure.

Authors:  Michio Kuwahara; Seiji Inoshita; Yukiko Nakano; Yoshio Terada; Yoshiro Takano; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

3.  Secondary hyperparathyroidism and target organs in chronic kidney disease.

Authors:  M Nikodimopoulou; S Liakos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 4.  Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia.

Authors:  T B Drüeke
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

5.  Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.

Authors:  M Klin; M Smogorzewski; Z Ni; G Zhang; S G Massry
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

6.  Experimental models of renal disease and the cardiovascular system.

Authors:  Rebecca C Grossman
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.